Ropes & Gray has been appointed by GlaxoSmithKline (GSK) to lead an internal investigation at the pharmaceutical giant, after Chinese officials alleged the company had engaged in bribery in China.

Chinese authorities have claimed executives at GSK used a network of middlemen to bribe doctors in return for prescribing the company’s drugs.